HCAT Financial Statements

Balance sheet, income statement, cash flow, and dividends for Health Catalyst Inc (HCAT).


$430.19M Market Cap.

As of 02/27/2025 5:00 PM ET (MRY) • Disclaimer

HCAT Market Cap. (MRY)


HCAT Shares Outstanding (MRY)


HCAT Assets (MRY)


Total Assets

$858.93M

Total Liabilities

$493.72M

Total Investments

$142.35M

HCAT Income (MRY)


Revenue

$306.58M

Net Income

-$69.50M

Operating Expense

$210.59M

HCAT Cash Flow (MRY)


CF Operations

$14.56M

CF Investing

-$22.90M

CF Financing

$151.75M

HCAT Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

HCAT Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$858,929,000 (22.39%)

$701,814,000 (-6.71%)

$752,286,000 (-9.59%)

$832,096,000 (44.03%)

Assets Current

$465,650,000 (18.37%)

$393,397,000 (-8.04%)

$427,795,000 (-15.85%)

$508,391,000 (54.15%)

Assets Non-Current

$393,279,000 (27.52%)

$308,417,000 (-4.95%)

$324,491,000 (0.24%)

$323,705,000 (30.56%)

Goodwill & Intangible Assets

$345,811,000 (30.97%)

$264,036,000 (-5.08%)

$278,171,000 (1.24%)

$274,760,000 (32.90%)

Shareholders Equity

$365,207,000 (-0.47%)

$366,919,000 (-13.67%)

$425,010,000 (-18.60%)

$522,098,000 (89.10%)

Property Plant & Equipment Net

$41,452,000 (4.57%)

$39,639,000 (-6.92%)

$42,586,000 (-4.19%)

$44,449,000 (18.24%)

Cash & Equivalents

$249,645,000 (134.90%)

$106,276,000 (-8.63%)

$116,312,000 (-39.81%)

$193,227,000 (110.13%)

Accumulated Other Comprehensive Income

-$835,000 (-2630.30%)

$33,000 (105.09%)

-$648,000 (-867.16%)

-$67,000 (-209.84%)

Deferred Revenue

$53,530,000 (-4.12%)

$55,830,000 (1.39%)

$55,066,000 (-4.33%)

$57,561,000 (17.42%)

Total Investments

$142,355,000 (-32.68%)

$211,452,000 (-14.45%)

$247,178,000 (-1.82%)

$251,754,000 (40.71%)

Investments Current

$142,355,000 (-32.68%)

$211,452,000 (-14.45%)

$247,178,000 (-1.82%)

$251,754,000 (40.71%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$57,182,000 (-5.16%)

$60,290,000 (25.68%)

$47,970,000 (-1.70%)

$48,801,000 (1.05%)

Trade & Non-Trade Payables

$11,433,000 (72.16%)

$6,641,000 (50.11%)

$4,424,000 (-5.73%)

$4,693,000 (-11.98%)

Accumulated Retained Earnings (Deficit)

-$1,186,672,000 (-6.22%)

-$1,117,170,000 (-11.83%)

-$999,023,000 (-13.67%)

-$878,860,000 (-21.11%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$402,265,000 (61.51%)

$249,068,000 (0.44%)

$247,974,000 (21.19%)

$204,611,000 (4.78%)

Debt Current

$234,796,000 (6892.14%)

$3,358,000 (-2.21%)

$3,434,000 (0.26%)

$3,425,000 (30.63%)

Debt Non-Current

$167,469,000 (-31.84%)

$245,710,000 (0.48%)

$244,540,000 (21.55%)

$201,186,000 (4.42%)

Total Liabilities

$493,722,000 (47.43%)

$334,895,000 (2.33%)

$327,276,000 (5.57%)

$309,998,000 (2.77%)

Liabilities Current

$325,850,000 (265.98%)

$89,034,000 (7.91%)

$82,510,000 (-11.33%)

$93,051,000 (5.70%)

Liabilities Non-Current

$167,872,000 (-31.72%)

$245,861,000 (0.45%)

$244,766,000 (12.82%)

$216,947,000 (1.56%)

HCAT Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$306,584,000 (3.60%)

$295,938,000 (7.13%)

$276,236,000 (14.18%)

$241,926,000 (28.11%)

Cost of Revenue

$165,805,000 (1.04%)

$164,105,000 (14.72%)

$143,049,000 (15.03%)

$124,354,000 (26.79%)

Selling General & Administrative Expense

$111,204,000 (-22.71%)

$143,880,000 (-3.58%)

$149,215,000 (-7.30%)

$160,961,000 (40.39%)

Research & Development Expense

$57,950,000 (-20.21%)

$72,627,000 (-4.03%)

$75,680,000 (20.64%)

$62,733,000 (17.22%)

Operating Expenses

$210,585,000 (-18.61%)

$258,730,000 (-5.29%)

$273,192,000 (4.58%)

$261,222,000 (39.77%)

Interest Expense

-$637,000 (93.00%)

-$9,106,000 (-642.67%)

$1,678,000 (-89.80%)

$16,458,000 (42.22%)

Income Tax Expense

$333,000 (-6.46%)

$356,000 (108.32%)

-$4,280,000 (37.95%)

-$6,898,000 (-477.72%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$69,502,000 (41.17%)

-$118,147,000 (14.01%)

-$137,403,000 (10.32%)

-$153,210,000 (-33.21%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$69,502,000 (41.17%)

-$118,147,000 (14.01%)

-$137,403,000 (10.32%)

-$153,210,000 (-33.21%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$69,502,000 (41.17%)

-$118,147,000 (14.01%)

-$137,403,000 (10.32%)

-$153,210,000 (-33.21%)

Weighted Average Shares

$60,185,000 (6.68%)

$56,418,000 (5.02%)

$53,722,000 (13.11%)

$47,495,000 (20.12%)

Weighted Average Shares Diluted

$60,185,000 (6.68%)

$56,418,000 (4.32%)

$54,080,000 (13.86%)

$47,495,000 (20.12%)

Earning Before Interest & Taxes (EBIT)

-$69,806,000 (44.99%)

-$126,897,000 (9.36%)

-$140,005,000 (2.54%)

-$143,650,000 (-37.28%)

Gross Profit

$140,779,000 (6.79%)

$131,833,000 (-1.02%)

$133,187,000 (13.28%)

$117,572,000 (29.53%)

Operating Income

-$69,806,000 (44.99%)

-$126,897,000 (9.36%)

-$140,005,000 (2.54%)

-$143,650,000 (-49.44%)

HCAT Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$22,902,000 (-212.86%)

$20,293,000 (152.01%)

-$39,021,000 (72.06%)

-$139,678,000 (-69.17%)

Net Cash Flow from Financing

$151,746,000 (5458.46%)

$2,730,000 (204.48%)

-$2,613,000 (-100.99%)

$264,084,000 (44.62%)

Net Cash Flow from Operations

$14,559,000 (144.01%)

-$33,080,000 (6.21%)

-$35,270,000 (-52.53%)

-$23,123,000 (11.57%)

Net Cash Flow / Change in Cash & Cash Equivalents

$143,369,000 (1528.55%)

-$10,036,000 (86.95%)

-$76,915,000 (-175.95%)

$101,273,000 (37.00%)

Net Cash Flow - Business Acquisitions and Disposals

-$80,277,000 (-604.68%)

-$11,392,000 (59.09%)

-$27,846,000 (40.45%)

-$46,763,000 (54.00%)

Net Cash Flow - Investment Acquisitions and Disposals

$73,760,000 (60.47%)

$45,965,000 (640.18%)

$6,210,000 (108.34%)

-$74,470,000 (-352.07%)

Capital Expenditure

-$15,877,000 (-20.63%)

-$13,162,000 (12.98%)

-$15,125,000 (11.40%)

-$17,072,000 (-85.50%)

Issuance (Repayment) of Debt Securities

$149,166,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$2,580,000 (-5.49%)

$2,730,000 (314.79%)

-$1,271,000 (-100.47%)

$270,374,000 (566.98%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

-$34,000 (-261.90%)

$21,000 (290.91%)

-$11,000 (-10.00%)

-$10,000 (-138.46%)

Share Based Compensation

$40,128,000 (-28.03%)

$55,756,000 (-22.67%)

$72,104,000 (10.68%)

$65,145,000 (71.63%)

Depreciation Amortization & Accretion

$44,116,000 (-2.43%)

$45,213,000 (-12.26%)

$51,528,000 (25.33%)

$41,113,000 (78.53%)

HCAT Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

45.90% (3.15%)

44.50% (-7.68%)

48.20% (-0.82%)

48.60% (1.04%)

Profit Margin

-22.70% (43.11%)

-39.90% (19.72%)

-49.70% (21.48%)

-63.30% (-3.94%)

EBITDA Margin

-8.40% (69.57%)

-27.60% (13.75%)

-32.00% (24.53%)

-42.40% (1.85%)

Return on Average Equity (ROAE)

-19.40% (36.60%)

-30.60% (5.26%)

-32.30% (-10.24%)

-29.30% (29.74%)

Return on Average Assets (ROAA)

-9.10% (44.51%)

-16.40% (10.38%)

-18.30% (0.54%)

-18.40% (7.54%)

Return on Sales (ROS)

-22.80% (46.85%)

-42.90% (15.38%)

-50.70% (14.65%)

-59.40% (-7.22%)

Return on Invested Capital (ROIC)

-25.50% (-1.19%)

-25.20% (5.97%)

-26.80% (11.26%)

-30.20% (-11.44%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-6.15 (-38.75%)

-4.43 (-6.72%)

-4.15 (66.15%)

-12.27 (18.00%)

Price to Sales Ratio (P/S)

1.39 (-21.36%)

1.76 (-14.61%)

2.07 (-73.43%)

7.78 (-14.66%)

Price to Book Ratio (P/B)

1.18 (-18.87%)

1.45 (6.06%)

1.37 (-65.34%)

3.95 (-41.04%)

Debt to Equity Ratio (D/E)

1.35 (48.08%)

0.91 (18.57%)

0.77 (29.63%)

0.59 (-45.65%)

Earnings Per Share (EPS)

-1.15 (44.98%)

-2.09 (18.36%)

-2.56 (20.74%)

-3.23 (-11.00%)

Sales Per Share (SPS)

5.09 (-2.88%)

5.25 (2.00%)

5.14 (0.94%)

5.09 (6.66%)

Free Cash Flow Per Share (FCFPS)

-0.02 (97.32%)

-0.82 (12.58%)

-0.94 (-10.87%)

-0.85 (5.37%)

Book Value Per Share (BVPS)

6.07 (-6.70%)

6.5 (-17.79%)

7.91 (-28.04%)

10.99 (57.43%)

Tangible Assets Book Value Per Share (TABVPS)

8.53 (9.87%)

7.76 (-12.07%)

8.82 (-24.80%)

11.73 (25.07%)

Enterprise Value Over EBIT (EV/EBIT)

-7 (-40.00%)

-5 (0.00%)

-5 (64.29%)

-14 (22.22%)

Enterprise Value Over EBITDA (EV/EBITDA)

-18.15 (-115.70%)

-8.41 (-5.44%)

-7.98 (58.86%)

-19.39 (18.05%)

Asset Turnover

0.4 (-2.20%)

0.41 (11.72%)

0.37 (26.12%)

0.29 (-11.01%)

Current Ratio

1.43 (-67.66%)

4.42 (-14.77%)

5.18 (-5.11%)

5.46 (45.86%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$1,318,000 (97.15%)

-$46,242,000 (8.24%)

-$50,395,000 (-25.38%)

-$40,195,000 (-13.70%)

Enterprise Value (EV)

$466,197,942 (-32.16%)

$687,235,000 (-2.65%)

$705,976,513 (-64.50%)

$1,988,748,709 (2.96%)

Earnings Before Tax (EBT)

-$69,169,000 (41.28%)

-$117,791,000 (16.86%)

-$141,683,000 (11.51%)

-$160,108,000 (-37.77%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$25,690,000 (68.55%)

-$81,684,000 (7.68%)

-$88,477,000 (13.71%)

-$102,537,000 (-25.64%)

Invested Capital

$339,888,000 (-30.85%)

$491,536,000 (-6.06%)

$523,267,000 (10.01%)

$475,669,000 (23.14%)

Working Capital

$139,800,000 (-54.07%)

$304,363,000 (-11.85%)

$345,285,000 (-16.87%)

$415,340,000 (71.80%)

Tangible Asset Value

$513,118,000 (17.21%)

$437,778,000 (-7.66%)

$474,115,000 (-14.93%)

$557,336,000 (50.23%)

Market Capitalization

$430,192,942 (-19.28%)

$532,916,000 (-8.43%)

$582,003,513 (-71.78%)

$2,062,430,709 (11.49%)

Average Equity

$358,614,000 (-7.11%)

$386,081,500 (-9.16%)

$425,010,000 (-18.60%)

$522,098,000 (89.10%)

Average Assets

$764,702,750 (5.84%)

$722,484,500 (-3.96%)

$752,286,000 (-9.59%)

$832,096,000 (44.03%)

Invested Capital Average

$273,815,250 (-45.65%)

$503,794,750 (-3.72%)

$523,267,000 (10.01%)

$475,669,000 (23.14%)

Shares

60,847,658 (5.73%)

57,550,324 (5.11%)

54,751,036 (5.18%)

52,055,293 (22.49%)